Modeling breast cancer-associated c-Src and EGFR overexpression in human MECs: c-Src and EGFR cooperatively promote aberrant three-dimensional acinar structure and invasive behavior

被引:68
作者
Dimri, Manjari
Naramura, Mayumi
Duan, Lei
Chen, Jing
Ortega-Cava, Cesar
Chen, Gengsheng
Goswami, Rasna
Fernandes, Norvin
Gao, Qingshen
Dimri, Goberdhan P.
Band, Vimla
Band, Hamid
机构
[1] Evanston NW Healthcare Res Inst, Dept Med, Feinberg Sch Med, Div Mol Oncol, Evanston, IL 60201 USA
[2] Evanston NW Healthcare Res Inst, Dept Med, Feinberg Sch Med, Div Canc Biol, Evanston, IL 60201 USA
[3] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL USA
[4] Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
D O I
10.1158/0008-5472.CAN-06-2580
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Epidermal growth factor receptor (EGFR), a member of the ErbB family of receptor tyrosine kinases, is overexpressed in as many as 60% cases of breast and other cancers. EGFR overexpression is a characteristic of highly aggressive molecular subtypes of breast cancer with basal-like and BRCA1 mutant phenotypes distinct from ErbB2-overexpressing breast cancers. Yet, EGFR is substantially weaker compared with ErbB2 in promoting the oncogenic transformation of nontumorigenic human mammary epithelial cells (human MEC), suggesting a role for cooperating oncogenes. Here, we have modeled the co-overexpression of EGFR and a biologically and clinically relevant potential modifier c-Src in two distinct immortal but nontumorigenic human MECs. Using a combination of morphologic analysis and confocal imaging of polarity markers in three-dimensional Matrigel culture together with functional analyses of early oncogenic traits, we show for the first time that EGFR and c-Src co-overexpression but not EGFR or c-Src overexpression alone unleashes an oncogenic signaling program that leads to hyperproliferation and loss of polarity in three-dimensional acinar cultures, marked enhancement of migratory and invasive behavior, and anchorage-independent growth. Our results establish that EGFR overexpression in an appropriate context (modeled here using c-Src overexpression) can initiate oncogenic transformation of nontumorigenic human MECs and provide a suitable in vitro model to interrogate human breast cancer-relevant oncogenic signaling pathways initiated by overexpressed EGFR and to identify modifiers of EGFR-mediated breast oncogenesis.
引用
收藏
页码:4164 / 4172
页数:9
相关论文
共 50 条
[31]   POTENTIATION OF EPIDERMAL GROWTH-FACTOR RECEPTOR-MEDIATED ONCOGENESIS BY C-SRC - IMPLICATIONS FOR THE ETIOLOGY OF MULTIPLE HUMAN CANCERS [J].
MAA, MC ;
LEU, TH ;
MCCARLEY, DJ ;
SCHATZMAN, RC ;
PARSONS, SJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (15) :6981-6985
[32]   Autocrine epidermal growth factor signaling stimulates directionally persistent mammary epithelial cell migration [J].
Maheshwari, G ;
Wiley, HS ;
Lauffenburger, DA .
JOURNAL OF CELL BIOLOGY, 2001, 155 (07) :1123-1128
[33]   ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini [J].
Muthuswamy, SK ;
Li, DM ;
Lelievre, S ;
Bissell, MJ ;
Brugge, JS .
NATURE CELL BIOLOGY, 2001, 3 (09) :785-792
[34]  
Nam JS, 2002, CLIN CANCER RES, V8, P2430
[35]   Modeling dynamic reciprocity: Engineering three-dimensional culture models of breast architecture, function, and neoplastic transformation [J].
Nelson, CM ;
Bissell, MJ .
SEMINARS IN CANCER BIOLOGY, 2005, 15 (05) :342-352
[36]   The role of overexpressed HER2 in transformation [J].
Neve, RM ;
Lane, HA ;
Hynes, NE .
ANNALS OF ONCOLOGY, 2001, 12 :9-13
[37]   EGFR and cancer prognosis [J].
Nicholson, RI ;
Gee, JMW ;
Harper, ME .
EUROPEAN JOURNAL OF CANCER, 2001, 37 :S9-S15
[38]  
OKABAYASHI Y, 1994, J BIOL CHEM, V269, P18674
[39]   INTERACTION WITH BASEMENT-MEMBRANE SERVES TO RAPIDLY DISTINGUISH GROWTH AND DIFFERENTIATION PATTERN OF NORMAL AND MALIGNANT HUMAN BREAST EPITHELIAL-CELLS [J].
PETERSEN, OW ;
RONNOVJESSEN, L ;
HOWLETT, AR ;
BISSELL, MJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (19) :9064-9068
[40]   The epidermal growth factor receptor-tyrosine kinase: A promising therapeutic target in solid tumors [J].
Ritter, CA ;
Arteaga, CL .
SEMINARS IN ONCOLOGY, 2003, 30 (01) :3-11